In small cell lung cancer lines, both gain-of-function and loss-of-function strategies have shown that POU3F2 regulates the expression of achaete-scute homolog-like 1 (ASCL1), which functions as a growth enhancer and helps tumor cells escape anti-cancer immune responses [20]. This evidence concerns the gene POU3F2 and small cell lung carcinoma.